International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ.
Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH, Wan CL, Dai HP, Xue SL.
Ann Hematol. 2023 Aug;102(8):2001-2013. doi: 10.1007/s00277-023-05286-3. Epub 2023 May 25.
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P, Mecucci C, La Starza R.
Genes (Basel). 2021 Jul 23;12(8):1118. doi: 10.3390/genes12081118.
T-lymphoblastic leukemia/lymphoma.
You MJ, Medeiros LJ, Hsi ED.
Am J Clin Pathol. 2015 Sep;144(3):411-22. doi: 10.1309/AJCPMF03LVSBLHPJ.
Classification and risk stratification in T-lineage acute lymphoblastic leukemia.
Pölönen P, Mullighan CG, Teachey DT.
Blood. 2025 Apr 3;145(14):1464-1474. doi: 10.1182/blood.2023022920.
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Jain N, Lamb AV, O'Brien S, Ravandi F, Konopleva M, Jabbour E, Zuo Z, Jorgensen J, Lin P, Pierce S, Thomas D, Rytting M, Borthakur G, Kadia T, Cortes J, Kantarjian HM, Khoury JD.
Blood. 2016 Apr 14;127(15):1863-9. doi: 10.1182/blood-2015-08-661702. Epub 2016 Jan 8.
T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
Kroeze E, Loeffen JLC, Poort VM, Meijerink JPP.
Blood Adv. 2020 Jul 28;4(14):3466-3473. doi: 10.1182/bloodadvances.2020001822.
Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, Bassan R.
Curr Oncol Rep. 2022 Jan;24(1):1-12. doi: 10.1007/s11912-021-01168-x. Epub 2022 Jan 20.
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
Temple WC, Mueller S, Hermiston ML, Burkhardt B.
Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16.
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma.
DuVall AS, Wesevich A, Larson RA.
Curr Hematol Malig Rep. 2023 Dec;18(6):217-225. doi: 10.1007/s11899-023-00706-7. Epub 2023 Jul 25.
